Literature DB >> 31279609

Detection and characterization of hepatitis E virus genotype 3 in HIV-infected patients and blood donors from southern Brazil.

Cláudio Moss da Silva1, Jaqueline Mendes Oliveira2, Raúl Andrés Mendoza-Sassi1, Andreza Soriano Figueiredo3, Luísa Dias da Mota1, Maíba Mikhael Nader4, Noemi Rovaris Gardinali3, Yohan Britto Kevorkian5, Sarah Beatriz Salamene Salvador3, Marcelo Alves Pinto3, Ana Maria Barral Martinez1.   

Abstract

BACKGROUND: Hepatitis E virus genotype 3 (HEV-3) infection usually causes self-limited acute hepatitis. In immunosuppressed patients, HEV-3 infection can rapidly progress to chronic hepatitis and cirrhosis. In southern Brazil, data on HEV seroprevalence are scarce.
METHODS: Testing for HEV RNA and antibodies (anti-HEV) was performed for 320 HIV-infected patients followed at the HIV/AIDS Service of the Federal University of Rio Grande between 2012 and 2013, as well as 281 blood donor samples obtained in 2015. Variables associated with anti-HEV positivity were assessed by multivariable logistic regression analysis.
RESULTS: HIV and blood donor groups showed similar HEV seroprevalence (6.7% and 7.1%, respectively). Risk factors associated with anti-HEV detection were older age, marital status, a higher number of sexual partners, poor sanitation, and alcohol use (HIV group), and living in a rural area (blood donors). HEV RNA was detected in eight serum samples from HIV-infected patients and in one blood donor, who was also positive for anti-HEV IgM and IgG.
CONCLUSIONS: The prevalence rates of HEV infection were comparable between HIV-seropositive patients who were not severely immunocompromised and blood donors. The blood donor's HEV isolate showed high similarity with swine HEV strains from Brazilian herds in the same region, thus indicating a potential risk of foodborne and parenteral transmission via blood transfusion.
Copyright © 2019 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Blood donors; HEV; HEV RNA; HIV; Hepatitis E virus; Seroprevalence

Mesh:

Substances:

Year:  2019        PMID: 31279609     DOI: 10.1016/j.ijid.2019.06.027

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  3 in total

1.  Hepatitis E in a Portuguese cohort of human immunodeficiency virus positive patients: High seroprevalence but no chronic infections.

Authors:  Rita Filipe; Beatriz Prista-Leão; André Silva-Pinto; Isabel Abreu; Rosário Serrão; Rosário Costa; Edite Guedes; Joana Sobrinho-Simões; António Sarmento; Carmo Koch; Lurdes Santos
Journal:  Health Sci Rep       Date:  2022-05-20

Review 2.  HIV and Substance Use in Latin America: A Scoping Review.

Authors:  Hanalise V Huff; Paloma M Carcamo; Monica M Diaz; Jamie L Conklin; Justina Salvatierra; Rocio Aponte; Patricia J Garcia
Journal:  Int J Environ Res Public Health       Date:  2022-06-12       Impact factor: 4.614

3.  Hepatitis E Virus in People Who Use Crack-Cocaine: A Cross-Sectional Study in a Remote Region of Northern Brazil.

Authors:  Raquel Silva do Nascimento; Karen Lorena N Baia; Samara Borges de Souza; Guilherme Martins G Fontoura; Patrícia Ferreira Nunes; Luiz Fernando A Machado; Emil Kupek; Benedikt Fischer; Luísa Caricio Martins; Aldemir B Oliveira-Filho
Journal:  Viruses       Date:  2021-05-17       Impact factor: 5.048

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.